Bortezomib appears to overcome the poor prognosis conferred...

Leukemia 2006 Vol. 21; Iss. 1

Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials

Jagannath, S, Richardson, P G, Sonneveld, P, Schuster, M W, Irwin, D, Stadtmauer, E A, Facon, T, Harousseau, J-L, Cowan, J M, Anderson, K C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Year:
2006
Language:
english
Pages:
7
DOI:
10.1038/sj.leu.2404442
File:
PDF, 161 KB
english, 2006
Conversion to is in progress
Conversion to is failed